[Development of criteria for vaccine safety from the position of the immunopathology of infectious diseases].
D000454:Aleutian Mink Disease Virus / Q000276:immunology; D000818:Animals; D001327:Autoimmune Diseases / Q000209:etiology; D001500:BCG Vaccine / Q000009:adverse effects; D005838:Genotype; D006801:Humans; D007154:Immune System Diseases / Q000209:etiology*; D007251:Influenza, Human; D008457:Measles / Q000209:etiology; D008458:Measles Vaccine / Q000009:adverse effects; D051379:Mice; D008807:Mice, Inbred BALB C; D008808:Mice, Inbred CBA; D011819:Rabies Vaccines / Q000009:adverse effects; D012136:Respiratory Syncytial Viruses; D012141:Respiratory Tract Infections; D014612:Vaccines / Q000009:adverse effects*; D014613:Vaccines, Attenuated; D014765:Viral Vaccines / Q000009:adverse effects; D015005:Yellow fever virus / Q000276:immunology
D001500:BCG Vaccine; D008458:Measles Vaccine; D011819:Rabies Vaccines; D014612:Vaccines; D014613:Vaccines, Attenuated; D014765:Viral Vaccines
Razrabotka kriteriev bezopasnosti vaktsin s pozitsiĭ immunopatologii infektsionnykh bolezni